stockrowHUTCHMED (China) Limited Sponsored ADR
HCM Healthcare Drug Manufacturers Specialty & Generic
HUTCHMED (China) Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $548.5 million, down 13.0% from fiscal 2024.
Follow HCM
Alert me
HUTCHMED (China) Limited Sponsored ADR (HCM) Revenue growth
HUTCHMED (China) Limited Sponsored ADR's revenue growth over the twelve months to 30 June 2023 was 245.2%. Over the past ten years it has ranged from −24.8% (fiscal 2024) to 104.1% (fiscal 2015); the current reading is higher than 18% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 5.22% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −13.0% | 11.84 |
| FY2024 | −24.8% | (121.32) |
| FY2023 | 96.5% | 76.79 |
| FY2022 | 19.7% | (36.48) |
| FY2021 | 56.2% | 44.94 |
| FY2020 | 11.3% | 15.58 |
| FY2019 | −4.31% | 6.92 |
| FY2018 | −11.2% | (22.86) |
| FY2017 | 11.6% | (9.62) |
| FY2016 | 21.3% | (82.81) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2023 | 510.1% | 403.12 |
| Dec 2022 | 107.0% | (178.06) |
| Jun 2022 | 285.0% | 236.16 |
| Jun 2021 | 48.9% | (32.84) |
| 10 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ALVO Alvotech compare | 364.3% |
| HCM HUTCHMED (China) Limited Sponsored ADR | 245.2% |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 60.3% |
| XERS Xeris Biopharma Holdings, Inc. compare | 38.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 25.9% |
| PBH Prestige Consumer Healthcare Inc. compare | 5.10% |
| PRGO Perrigo Company plc compare | −4.47% |
| TRLV Trulieve Cannabis Corp. compare | −9.09% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on HCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement